Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
about
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tablesCardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.Novel therapeutic strategies for adult obese asthmatics.Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.Cocoa and chocolate in human health and diseaseEffects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial.Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim.Mitochondrial dysfunction in metabolic syndrome and asthma.Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases.Effects of spinach nitrate on insulin resistance, endothelial dysfunction markers and inflammation in mice with high-fat and high-fructose consumption.Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.Cellular ADMA: regulation and action.Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 DiabetesCardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.Use of dark chocolate for diabetic patients: a review of the literature and current evidence.Transcriptional changes in mesenteric and subcutaneous adipose tissue from Holstein cows in response to plane of dietary energy.Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle.Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women.PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
P2860
Q26865426-27E373AD-4F99-4202-BCAB-2E529429C243Q34099243-7787731D-B77F-44DE-86CD-F412CD0E9AD8Q34290008-21C57DDD-3AAF-4FC8-A6FB-25B4BC55C73AQ34448584-C38C100E-CEC0-4F2C-8564-03BA52A350A4Q36173994-ED6A837B-5C09-4230-9D32-CE3F00705B34Q36417456-B7C33DCA-9CC4-4BEA-AC6D-045976F8F58CQ36845012-E7C540C4-8CFD-4762-AB7C-809440F480B1Q36855785-D970D047-8F42-4CE1-B34C-090E8C913FBAQ36942788-F6CD6C57-66E4-401E-95E2-DC78A6243F87Q37009925-BA1216D4-BC0E-45C7-827B-087A6709FBA7Q37247258-7E368D74-BB79-46DB-A2A8-ED50521A20BBQ37365823-D9C4E46C-C873-4B5C-8191-B8E09650A11BQ37399711-B1F88F83-C4D3-4776-B1AF-D95B1B3B1650Q37403981-57827244-99AC-4A13-8E5C-90B8B5F8A3E8Q37963876-A7A691E4-4002-4C05-9E4F-18DA3DA11462Q37980497-10F15939-0956-45F6-9F1D-6036AA101E42Q41205365-6DFC91C6-A3B9-4780-9BE8-60BE13C02BF8Q42078341-FF00F0BA-6325-46E9-982B-B2F6A1C6CB28Q44130303-121D0E46-9788-4CFA-9BEC-22F335814446Q44993864-59E011F5-1DAA-4095-8517-8E37641267E7Q47137849-D5D541F6-7A1D-46F8-9535-AD67FEA88514Q49202628-D6D9B313-14BD-4049-AED4-AF0818955CEDQ54531644-F4EA1068-5120-4AE2-9BBF-D9B399F31646Q58699564-037190E3-895B-4975-AE7C-83038D0DA517
P2860
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@ast
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@en
type
label
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@ast
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@en
prefLabel
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@ast
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@en
P2093
P2860
P1433
P1476
Insulin resistance: potential ...... oxide synthase inhibitor ADMA.
@en
P2093
Carl E Mondon
John P Cooke
Karsten Sydow
P2860
P304
P356
10.1191/1358863X05VM604OA
P478
10 Suppl 1
P577
2005-07-01T00:00:00Z